Fellow explorer! We are currently migrating content published before 2024. Archives of our old website are available at Wayback Machine.

The Role of Anti-VEGF Therapies in Neovascular Age-Related Macular Degeneration (nAMD)

Introduction

Age-related macular degeneration (AMD) is the leading cause of vision impairment and irreversible blindness among individuals over the age of 55 in developed countries [1, 2, 3]. It is characterized by progressive damage to the macula, a key component of the eye’s retina. Since the retina is responsible for converting light into neural signals essential for vision, any damage can severely impair both central and peripheral vision, significantly impacting the quality of life for millions of people.